You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EGFR/cMET/cMET

Showing 1 - 25 of 2,008
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Other Solid Tumors Trial in Australia (GB263T)

Recruiting
  • NSCLC
  • Other Solid Tumors
  • GB263T
  • Saint Leonards, New South Wales, Australia
  • +3 more
Aug 3, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Capmatinib, Nazartinib)

Terminated
  • Non Small Cell Lung Cancer
  • Boston, Massachusetts
  • +18 more
Jul 20, 2022

NSCLC Trial in Worldwide (INC280 (capmatinib))

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • INC280 (capmatinib)
  • Long Beach, California
  • +95 more
Dec 29, 2022

Advanced Solid Malignancies Trial in Worldwide (Ami-LC-MD, Ami-LC, Ami-HC)

Recruiting
  • Advanced Solid Malignancies
  • West Hollywood, California
  • +13 more
Jan 31, 2023

Non Small Cell Lung Cancer Trial in Worldwide (EGF816, INC280, Nivolumab)

Terminated
Has Results
  • Non Small Cell Lung Cancer
  • Houston, Texas
  • +12 more
Jan 31, 2022

Non-Small-Cell Lung Cancer Trial in Worldwide (Amivantamab, Lazertinib, Carboplatin)

Recruiting
  • Non-Small-Cell Lung Cancer
  • Duarte, California
  • +100 more
Jan 31, 2023

Solid Tumor, NSCLC, Head Neck Cancer Trial in China (MCLA-129)

Recruiting
  • Solid Tumor
  • +3 more
  • Baoding, China
  • +63 more
Dec 19, 2021

NSCLC Trial in Worldwide (INC280 single agent, erlotinib)

Terminated
  • Non-Small Cell Lung Cancer
  • Los Angeles, California
  • +31 more
Feb 20, 2020

NSCLC Trial in Worldwide (Lazertinib, Amivantamab, Carboplatin)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Los Angeles, California
  • +83 more
Jan 31, 2023

Advanced Solid Tumors Which Are cMET-dependent Trial in Worldwide (Capmatinib, Nazartinib, Gefitinib)

Recruiting
  • Advanced Solid Tumors Which Are cMET-dependent
  • Boston, Massachusetts
  • +12 more
Jan 27, 2023

cMET Dysegulation Advanced Solid Tumors Trial in Worldwide (INC280)

Completed
  • cMET Dysegulation Advanced Solid Tumors
  • Indianapolis, Indiana
  • +16 more
Dec 16, 2020

cMET-dysregulated Advanced Solid Tumors Trial in Worldwide (INC280, Midazolam, Caffeine)

Completed
  • cMET-dysregulated Advanced Solid Tumors
  • Atlanta, Georgia
  • +11 more
Dec 8, 2020

cMET-dysregulated Advanced Solid Tumors Trial in Worldwide (INC280, digoxin, rosuvastatin)

Completed
  • cMET-dysregulated Advanced Solid Tumors
  • Atlanta, Georgia
  • +14 more
Dec 8, 2020

Malignant Melanoma, Breast Cancer Trial in Philadelphia (T cells modified with RNA anti -cMET CAR)

Terminated
  • Malignant Melanoma
  • Breast Cancer
  • T cells modified with RNA anti -cMET CAR
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Mar 30, 2020

Metastatic Lung Non-Small Cell Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Orange,

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +8 more
  • Orange, California
  • +2 more
Aug 10, 2022

NSCLC, NSCLC Stage IV, NSCLC Stage IIIB Trial (MYTX-011)

Not yet recruiting
  • NSCLC
  • +5 more
  • (no location specified)
Dec 7, 2022

Advanced Solid Tumor, Metastatic Colorectal Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Irvine, Chicago, Boston

Not yet recruiting
  • Advanced Solid Tumor
  • +4 more
  • Irvine, California
  • +2 more
Nov 27, 2023

Solid Tumor, Adult Trial in Tainan, Taipei county, Taipei (HLX55)

Recruiting
  • Solid Tumor, Adult
  • Tainan, Taiwan
  • +3 more
Apr 29, 2020

Solid Tumor, Colorectal Cancer Trial in Oxford (PF-02341066, PD-0325901, Binimetinib)

Completed
Has Results
  • Solid Tumor
  • Colorectal Cancer
  • Oxford, United Kingdom
    Oxford University Hospital NHS Trust
Jun 14, 2021

Colorectal Cancer Metastatic, C-met Overexpression Trial in Rozzano (Tivantinib (ARQ197))

Completed
  • Colorectal Cancer Metastatic
  • C-met Overexpression
  • Tivantinib (ARQ197)
  • Rozzano, Milano, Italy
    Istituto Clinico Humanitas
Sep 8, 2022

Tumors, Tumor Metastasis, Metastatic Gastrointestinal Carcinoid Tumor Trial in China, United States (EMB-01)

Recruiting
  • Neoplasms
  • +2 more
  • Canton, Ohio
  • +3 more
Apr 12, 2022

Hepatic Impairment Trial in United States (INC280)

Completed
  • Hepatic Impairment
  • Miami, Florida
  • +4 more
Dec 8, 2020

Testing Practices for Common Solid Cancers in Precision Oncology

Active, not recruiting
  • Breast Carcinoma
  • +5 more
  • Survey Administration
  • Chicago, Illinois
    Center for Business Models in Healthcare
Dec 29, 2021

Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

Not yet recruiting
  • Lung Cancer
  • Non Small Cell Lung Cancer
  • Amivantamab 1050mg
  • +2 more
  • Aurora, Colorado
  • +2 more
Apr 25, 2023

Colorectal Cancer Trial (Cetuximab, mFOLFOX6, FOLFIRI)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 29, 2021